To the central content area :::

TPEx

Listed Companies

ECO-Fin
:::
:::Listed Companies > Listed Companies Info. > Emerging Stock Board Companies > Listed Company Profile

ESM Companies

For foreign Emerging Stock Board enterprises, ”*- country of incorporation” indicates stocks without par value or with par value other than NT$10, and ”- country of incorporation” indicates stocks with par value of NT$10 per share.
6610 TWi Biotech.
中文
Basic information
Chairman President Spokesperson Telephone Address ESM Registration Date
Jessica Wu Chen-En Tsai Jessica Wu 02-26571788 8F, No.41, Lane 221, Kang Chien Rd.,Nei Hu Dist., Taipei 11494, Taiwan 2016/12/27
Industry
category
Key businesses
Biotechnology and Medical Care TWi Biotechnology is dedicated to developing new drugs for innate immunity-related diseases,including diabetes mellitus,gout,ophthalmic and dermal conditions,and others.The strategy of TWi Biotechnology is to focus on the development of treatments for unmet medical needs,such as severe rare diseases without therapies, or treatments that represent a significant breakthrough for the disease. In order to achieve these goals in a highly efficient manner, and to provide safe and effective new drugs to patients with urgent needs, TWi Biotechnology has adopted a drug repositioning strategy. While based in Taiwan, TWi Biotechnology is targeting United States as its primary market.
 
Market info
Latest trading info Historic trading info
 
Financial data
Cash flows statement Item
Amount(NTD, in thousands)
Cash flows from operating activities
Cash flows from investing activities
Cash flows from financing activities
Consolidated/Individual
balance sheet
Current assets
Non-current assets
Total assets
Current liabilities
Non-current liabilities
Total liabilities
Share capital
Capital surplus
Retained earnings
Other equity interest
Treasury shares
Total equity attributable to owners of parent
Non-controlling interests
Total equity
Book Value per share(NT$)
Consolidated/Individual
profit and loss
statement
Operating revenue
Operating costs
Gross profit from operations
Operating expenses
Net other income (expenses)
Net operating income
Non-operating income and expenses
Profit before tax
Tax expense
Profit from continuing operations
Profit from discontinued operations
Profit
Other comprehensive income
Comprehensive income
Basic earnings per share
 Auditor's report on latest financial statements: auditor's report:
 Investors may find more detailed information on the company by visiting the Market Observation Post System.。
 The information disclosed here concerning foreign enterprises consists of amounts provided in consolidated financial statements.